Company registration number 08078004 (England and Wales)
TOTAL MEDCARE UK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024
PAGES FOR FILING WITH REGISTRAR
TOTAL MEDCARE UK LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
TOTAL MEDCARE UK LIMITED
BALANCE SHEET
AS AT
31 MAY 2024
31 May 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investments
2
427,452
427,432
Current assets
Debtors
3
47,480
-
0
Cash at bank and in hand
781
732
48,261
732
Creditors: amounts falling due within one year
4
(63,851)
(75,368)
Net current liabilities
(15,590)
(74,636)
Total assets less current liabilities
411,862
352,796
Creditors: amounts falling due after more than one year
5
(78,426)
(118,867)
Net assets
333,436
233,929
Capital and reserves
Called up share capital
10
10
Profit and loss reserves
333,426
233,919
Total equity
333,436
233,929

For the financial year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 11 June 2025 and are signed on its behalf by:
Mr Phalvinder Dhanjal
Mr G S Sabharwal
Director
Director
Company registration number 08078004 (England and Wales)
TOTAL MEDCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024
- 2 -
1
Accounting policies
Company information

Total Medcare UK Limited is a private company limited by shares incorporated in England and Wales. The registered office is Suite 3, Congress House, 14 Lyon Road, Harrow, Middlesex, England, HA1 2EN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

The Turnover is that of receipt of management charges and dividends.

1.3
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.4
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

TOTAL MEDCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2024
1
Accounting policies
(Continued)
- 3 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
427,432
427,432
Other investments other than loans
20
-
0
427,452
427,432
Movements in fixed asset investments
Shares in subsidiaries
Other investments
Total
£
£
£
Cost or valuation
At 1 June 2023
427,432
-
427,432
Additions
-
20
20
At 31 May 2024
427,432
20
427,452
Carrying amount
At 31 May 2024
427,432
20
427,452
At 31 May 2023
427,432
-
427,432
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
47,480
-
0
TOTAL MEDCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2024
- 4 -
4
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
45,229
38,797
Taxation and social security
15,622
34,571
Other creditors
3,000
2,000
63,851
75,368
5
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
78,426
118,867
2024-05-31 2023-06-01 false false false 11 June 2025 CCH Software CCH Accounts Production 2025.100 No description of principal activity Mr P S Dhanjal Mr G S Sabharwal 0 08078004 2023-06-01 2024-05-31 08078004 2024-05-31 08078004 2023-05-31 08078004 core:ShareCapital 2024-05-31 08078004 core:ShareCapital 2023-05-31 08078004 core:RetainedEarningsAccumulatedLosses 2024-05-31 08078004 core:RetainedEarningsAccumulatedLosses 2023-05-31 08078004 bus:Director1 2023-06-01 2024-05-31 08078004 bus:Director2 2023-06-01 2024-05-31 08078004 core:Non-currentFinancialInstruments 2024-05-31 08078004 core:Non-currentFinancialInstruments 2023-05-31 08078004 core:WithinOneYear 2024-05-31 08078004 core:WithinOneYear 2023-05-31 08078004 core:CurrentFinancialInstruments 2024-05-31 08078004 core:CurrentFinancialInstruments 2023-05-31 08078004 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 08078004 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 08078004 bus:FRS102 2023-06-01 2024-05-31 08078004 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 08078004 bus:FullAccounts 2023-06-01 2024-05-31 xbrli:pure xbrli:shares iso4217:GBP